U.S.-China Motor Vehicle Trade, and More from CRS
“In 2009, China overtook the United States to become both the world’s largest producer of and market for motor vehicles,” a new report from the Congressional Research Service notes.
That is not altogether bad news. “Every year since 2010, General Motors has sold more cars in China (through exports and its joint ventures there) than in the United States,” CRS said. “On the other hand, China maintains a number of trade and investment barriers that affect trade flows in autos and auto parts.”
See U.S.-Chinese Motor Vehicle Trade: Overview and Issues, May 13, 2013
Other new and updated reports from the Congressional Research Service that Congress has declined to make publicly available include the following.
Regulation of Fertilizers: Ammonium Nitrate and Anhydrous Ammonia, May 9, 2013
Haiti Under President Martelly: Current Conditions and Congressional Concerns, May 10, 2013
Women in Combat: Issues for Congress, May 9, 2013
The Peace Corps: Current Issues, May 10, 2013
Proposals to Eliminate Public Financing of Presidential Campaigns, May 10, 2013
The Federal Budget: Issues for FY2014 and Beyond, May 9, 2013
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.